News

Recent News

• Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice
• FluGen’s M2SR Phase 2 Human Challenge Trial Initial Results
• Flu shots urged as Madison’s FluGen plays role in effort for universal vaccine
• FluGen completes dosing of phase 2 study to assess effectiveness of novel influenza vaccine designed to protect against mismatched strains
• Experimental Nasal Influenza Vaccine Tested in Kids, Teens